Lisette Hilton
Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.
Controlling psoriasis symptoms eludes these patients
Optimal management of psoriasis symptoms falls short for about three in 10 patients with moderate plaque psoriasis and one in five with severe psoriasis, a study shows.
A cheeky fellow
Dr. Joe Niamtu’s go-to procedure for mid-face rejuvenation involves using cheek implants, an approach that’s relatively easy, safe, permanent and reversible.
Opposition to looming compounding practice changes
In this article, Dr. Murad Alam, M.D., president elect of the American Society for Dermatologic Surgery, addresses how changes in federal and state regulations that govern compounding medications could impact physicians and patients.
Neurologic changes that stem from biologic therapy
Physicians should be aware of the warning signs that a biologic agent could be to blame when patients experience subacute or rapidly progressive neurologic changes, researchers say.
Less itch and more sleep with baricitinib
A phase two study of adults with moderate-to-severe atopic dermatitis shows that once-daily oral Janus kinase (JAK) 1 and 2 inhibitor baricitinib relieved itch and improved sleep, a study shows.
The extent of affected body area in psoriasis may determine mortality
The risk of death for adults with psoriasis that impacts more than 10 percent of body surface area is about 1.8 times greater than adults without psoriasis, according to a new study.
Heart disease and mental health conditions more prevalent in psoriasis
Moderate-to-severe psoriasis and psoriatic arthritis patients are more likely than people without these conditions to have cardiovascular and mental comorbidities, as well as higher healthcare utilization and medical costs, primarily from pharmacy-related expenses, according to a recent retrospective study of U.S. Department of Defense patients.
Coordinated care lessons in dermatology
Coordinated care is gaining ground in medicine because it helps defragment a fragmented system, says Dr. Lindsay Strowd. Patients with chronic conditions, such as psoriasis, tend to benefit most.
Insights to improve your psoriasis care plan
Knowledge of outcomes data, adverse events may help physicians formulate effective treatment strategies, Dr. April Armstrong says.
Methotrexate outperforms cyclosporine in atopic dermatitis study
The duration of methotrexate administration proves to be longer than that of cyclosporine in atopic dermatitis, according to a small study that compared the two first-line immunosuppressive treatments for atopic dermatitis.